The report provides revenue of the global Induced Pluripotent Stem Cells market for the period 20162026, considering 2019 as the base year and 2026 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global market during the forecast period. The global Induced Pluripotent Stem Cells market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2020 to 2026.
The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the Induced Pluripotent Stem Cells market across the globe.
Request Coronavirus Impact Analysis on This [emailprotected] https://www.qyresearchmedical.com/sample/46706
A comprehensive estimate on the Induced Pluripotent Stem Cells market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of Induced Pluripotent Stem Cells during the forecast period. Price point comparison by region with global average price is also considered in the study.
It is pertinent to consider that in a volatile global economy, we havent just conducted Induced Pluripotent Stem Cells market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
Download Full Report https://www.qyresearchmedical.com/report/checkout/46706/3500
Drivers and Restraints
This section covers the various factors driving the global Advanced Driver Assistance Systems (ADAS) market. To understand the growth of the market it is important to analyze the various drivers present the market. It provides data by value and volume of different regions and their respective manufacturers. This data will elaborate on the market share occupied by them, predict their revenue concerning strategies, and how they will grow in the future. After explaining the drivers, the report further evaluates the new opportunities and current trends in the market.
Market restraints are factors hampering market growth. Studying these factors is equally pivotal as they help a reader need understand the weaknesses of the market.
Market Segmentation:
The report is divided into major categories comprising product, application, regions and others. Every segment is further sub-segmented into several sub-segmented that are deeply analyzed by experts to offer valuable information to the buyers and market players. Every segment is studied thoroughly in order to offer a better picture to the buyers and stakeholders to benefit from. Information like highest prevailing product, highly demanded product by the application segment and end users are rightly mentioned in the Induced Pluripotent Stem Cells report.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global Induced Pluripotent Stem Cells market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global Induced Pluripotent Stem Cells market.
Market segment by Type, the product can be split into Hepatocytes Fibroblasts Keratinocytes Amniotic Cells Others Market segment by Application, split into Academic Research Drug Development And Discovery Toxicity Screening Regenerative Medicine
Market segment by Regions/Countries, this report covers North America Europe China Japan Southeast Asia India Central & South America
In this study, the years considered to estimate the market size of Induced Pluripotent Stem Cells are as follows:
Major Players Covered in this Report
The updated market research report on Induced Pluripotent Stem Cells market allows the buyers and manufacturers to stay updated with the current market trends, ongoing happenings, and a clear picture on the market scenario. List of key players included in the research report will help the market vendors to know their market position and plan more operational strategies to gain topmost position among other players. The report offers crucial company information on each market player, such as company profile, financial information, and recently adopted growth strategies. This will help other existing players and the new entrants to plan strategies and establish their presence in the market.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
Fujifilm Holding Corporation Astellas Pharma Fate Therapeutics Bristol-Myers Squibb Company ViaCyte Celgene Corporation Aastrom Biosciences Acelity Holdings StemCells Japan Tissue Engineering Organogenesis
Regional Insights:
The Induced Pluripotent Stem Cells market is segmented as North America, South America, Europe, Asia Pacific, and Middle East and Africa. Researchers have thoroughly studied about the historical market. With extensive research, experts have offered details on the current and the forecast demand made by these regions. The Induced Pluripotent Stem Cells report also includes highlights on the prevailing product demanded by end users and end customers for better understanding of product demand by producers. This will help the producers and the marketing executives to plan their production quantity and plan effective marketing strategies to more buyers. Businesses can hence, increase their product portfolio and expand their global presence. Induced Pluripotent Stem Cells market research report further offers information on the unexplored areas in these regions to help the producers to plan promotional strategies and create demand for their new and updated products. This will again help the manufacturers to increase their customers and emerge as leaders in the near future.
TABLE OF CONTENT
1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Induced Pluripotent Stem Cells Revenue 1.4 Market Analysis by Type 1.4.1 Global Induced Pluripotent Stem Cells Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Hepatocytes 1.4.3 Fibroblasts 1.4.4 Keratinocytes 1.4.5 Amniotic Cells 1.4.6 Others 1.5 Market by Application 1.5.1 Global Induced Pluripotent Stem Cells Market Share by Application: 2020 VS 2026 1.5.2 Academic Research 1.5.3 Drug Development And Discovery 1.5.4 Toxicity Screening 1.5.5 Regenerative Medicine 1.6 Study Objectives 1.7 Years Considered
2 Global Growth Trends by Regions 2.1 Induced Pluripotent Stem Cells Market Perspective (2015-2026) 2.2 Induced Pluripotent Stem Cells Growth Trends by Regions 2.2.1 Induced Pluripotent Stem Cells Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Induced Pluripotent Stem Cells Historic Market Share by Regions (2015-2020) 2.2.3 Induced Pluripotent Stem Cells Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porters Five Forces Analysis 2.3.5 Induced Pluripotent Stem Cells Market Growth Strategy 2.3.6 Primary Interviews with Key Induced Pluripotent Stem Cells Players (Opinion Leaders)
3 Competition Landscape by Key Players 3.1 Global Top Induced Pluripotent Stem Cells Players by Market Size 3.1.1 Global Top Induced Pluripotent Stem Cells Players by Revenue (2015-2020) 3.1.2 Global Induced Pluripotent Stem Cells Revenue Market Share by Players (2015-2020) 3.1.3 Global Induced Pluripotent Stem Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Induced Pluripotent Stem Cells Market Concentration Ratio 3.2.1 Global Induced Pluripotent Stem Cells Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Induced Pluripotent Stem Cells Revenue in 2019 3.3 Induced Pluripotent Stem Cells Key Players Head office and Area Served 3.4 Key Players Induced Pluripotent Stem Cells Product Solution and Service 3.5 Date of Enter into Induced Pluripotent Stem Cells Market 3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026) 4.1 Global Induced Pluripotent Stem Cells Historic Market Size by Type (2015-2020) 4.2 Global Induced Pluripotent Stem Cells Forecasted Market Size by Type (2021-2026)
5 Induced Pluripotent Stem Cells Breakdown Data by Application (2015-2026) 5.1 Global Induced Pluripotent Stem Cells Market Size by Application (2015-2020) 5.2 Global Induced Pluripotent Stem Cells Forecasted Market Size by Application (2021-2026)
6 North America 6.1 North America Induced Pluripotent Stem Cells Market Size (2015-2020) 6.2 Induced Pluripotent Stem Cells Key Players in North America (2019-2020) 6.3 North America Induced Pluripotent Stem Cells Market Size by Type (2015-2020) 6.4 North America Induced Pluripotent Stem Cells Market Size by Application (2015-2020)
7 Europe 7.1 Europe Induced Pluripotent Stem Cells Market Size (2015-2020) 7.2 Induced Pluripotent Stem Cells Key Players in Europe (2019-2020) 7.3 Europe Induced Pluripotent Stem Cells Market Size by Type (2015-2020) 7.4 Europe Induced Pluripotent Stem Cells Market Size by Application (2015-2020)
8 China 8.1 China Induced Pluripotent Stem Cells Market Size (2015-2020) 8.2 Induced Pluripotent Stem Cells Key Players in China (2019-2020) 8.3 China Induced Pluripotent Stem Cells Market Size by Type (2015-2020) 8.4 China Induced Pluripotent Stem Cells Market Size by Application (2015-2020)
9 Japan 9.1 Japan Induced Pluripotent Stem Cells Market Size (2015-2020) 9.2 Induced Pluripotent Stem Cells Key Players in Japan (2019-2020) 9.3 Japan Induced Pluripotent Stem Cells Market Size by Type (2015-2020) 9.4 Japan Induced Pluripotent Stem Cells Market Size by Application (2015-2020)
10 Southeast Asia 10.1 Southeast Asia Induced Pluripotent Stem Cells Market Size (2015-2020) 10.2 Induced Pluripotent Stem Cells Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Induced Pluripotent Stem Cells Market Size by Type (2015-2020) 10.4 Southeast Asia Induced Pluripotent Stem Cells Market Size by Application (2015-2020)
11 India 11.1 India Induced Pluripotent Stem Cells Market Size (2015-2020) 11.2 Induced Pluripotent Stem Cells Key Players in India (2019-2020) 11.3 India Induced Pluripotent Stem Cells Market Size by Type (2015-2020) 11.4 India Induced Pluripotent Stem Cells Market Size by Application (2015-2020)
12 Central & South America 12.1 Central & South America Induced Pluripotent Stem Cells Market Size (2015-2020) 12.2 Induced Pluripotent Stem Cells Key Players in Central & South America (2019-2020) 12.3 Central & South America Induced Pluripotent Stem Cells Market Size by Type (2015-2020) 12.4 Central & South America Induced Pluripotent Stem Cells Market Size by Application (2015-2020)
13 Key Players Profiles 13.1 Fujifilm Holding Corporation 13.1.1 Fujifilm Holding Corporation Company Details 13.1.2 Fujifilm Holding Corporation Business Overview and Its Total Revenue 13.1.3 Fujifilm Holding Corporation Induced Pluripotent Stem Cells Introduction 13.1.4 Fujifilm Holding Corporation Revenue in Induced Pluripotent Stem Cells Business (2015-2020)) 13.1.5 Fujifilm Holding Corporation Recent Development 13.2 Astellas Pharma 13.2.1 Astellas Pharma Company Details 13.2.2 Astellas Pharma Business Overview and Its Total Revenue 13.2.3 Astellas Pharma Induced Pluripotent Stem Cells Introduction 13.2.4 Astellas Pharma Revenue in Induced Pluripotent Stem Cells Business (2015-2020) 13.2.5 Astellas Pharma Recent Development 13.3 Fate Therapeutics 13.3.1 Fate Therapeutics Company Details 13.3.2 Fate Therapeutics Business Overview and Its Total Revenue 13.3.3 Fate Therapeutics Induced Pluripotent Stem Cells Introduction 13.3.4 Fate Therapeutics Revenue in Induced Pluripotent Stem Cells Business (2015-2020) 13.3.5 Fate Therapeutics Recent Development 13.4 Bristol-Myers Squibb Company 13.4.1 Bristol-Myers Squibb Company Company Details 13.4.2 Bristol-Myers Squibb Company Business Overview and Its Total Revenue 13.4.3 Bristol-Myers Squibb Company Induced Pluripotent Stem Cells Introduction 13.4.4 Bristol-Myers Squibb Company Revenue in Induced Pluripotent Stem Cells Business (2015-2020) 13.4.5 Bristol-Myers Squibb Company Recent Development 13.5 ViaCyte 13.5.1 ViaCyte Company Details 13.5.2 ViaCyte Business Overview and Its Total Revenue 13.5.3 ViaCyte Induced Pluripotent Stem Cells Introduction 13.5.4 ViaCyte Revenue in Induced Pluripotent Stem Cells Business (2015-2020) 13.5.5 ViaCyte Recent Development 13.6 Celgene Corporation 13.6.1 Celgene Corporation Company Details 13.6.2 Celgene Corporation Business Overview and Its Total Revenue 13.6.3 Celgene Corporation Induced Pluripotent Stem Cells Introduction 13.6.4 Celgene Corporation Revenue in Induced Pluripotent Stem Cells Business (2015-2020) 13.6.5 Celgene Corporation Recent Development 13.7 Aastrom Biosciences 13.7.1 Aastrom Biosciences Company Details 13.7.2 Aastrom Biosciences Business Overview and Its Total Revenue 13.7.3 Aastrom Biosciences Induced Pluripotent Stem Cells Introduction 13.7.4 Aastrom Biosciences Revenue in Induced Pluripotent Stem Cells Business (2015-2020) 13.7.5 Aastrom Biosciences Recent Development 13.8 Acelity Holdings 13.8.1 Acelity Holdings Company Details 13.8.2 Acelity Holdings Business Overview and Its Total Revenue 13.8.3 Acelity Holdings Induced Pluripotent Stem Cells Introduction 13.8.4 Acelity Holdings Revenue in Induced Pluripotent Stem Cells Business (2015-2020) 13.8.5 Acelity Holdings Recent Development 13.9 StemCells 13.9.1 StemCells Company Details 13.9.2 StemCells Business Overview and Its Total Revenue 13.9.3 StemCells Induced Pluripotent Stem Cells Introduction 13.9.4 StemCells Revenue in Induced Pluripotent Stem Cells Business (2015-2020) 13.9.5 StemCells Recent Development 13.10 Japan Tissue Engineering 13.10.1 Japan Tissue Engineering Company Details 13.10.2 Japan Tissue Engineering Business Overview and Its Total Revenue 13.10.3 Japan Tissue Engineering Induced Pluripotent Stem Cells Introduction 13.10.4 Japan Tissue Engineering Revenue in Induced Pluripotent Stem Cells Business (2015-2020) 13.10.5 Japan Tissue Engineering Recent Development 13.11 Organogenesis 10.11.1 Organogenesis Company Details 10.11.2 Organogenesis Business Overview and Its Total Revenue 10.11.3 Organogenesis Induced Pluripotent Stem Cells Introduction 10.11.4 Organogenesis Revenue in Induced Pluripotent Stem Cells Business (2015-2020) 10.11.5 Organogenesis Recent Development
14 Analysts Viewpoints/Conclusions
15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details
Download Full Report https://www.qyresearchmedical.com/report/checkout/46706/3500
Contact Us:
QYResearch Medical
URL http://www.qyresearchmedical.com/
Mailing Address : Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Any Assistance, Email [emailprotected]
- NIH awards nearly $2M to Huebsch for study | The Source - Washington University in St. Louis Newsroom - August 31st, 2021
- Shoreline Launches with $4 Billion in Partnerships PharmaLive - PharmaLive - August 31st, 2021
- Bone Therapeutics announces topline results from Phase III knee osteoarthritis study with its enhanced viscosupplement JTA-004 - GlobeNewswire - August 31st, 2021
- Roslin Tech in multi-million bid to fund sustainable food - HeraldScotland - August 31st, 2021
- Global Induced Pluripotent Stem Cells Market Industry Analysis, Post COVID-19 Impact, Emerging Trends, Business Growth by 2027||Fate Therapeutics,... - July 22nd, 2021
- Bayer's BlueRock Therapeutics gains FDA fast track for Parkinson's disease cell therapy - PMLiVE - July 22nd, 2021
- Global Induced Pluripotent Stem Cell (iPSC) Market to Reach $2.3 Billion by 2026 - PRNewswire - July 7th, 2021
- Impact of NK cell-based therapeutics for Lung Cancer Therapy | BTT - Dove Medical Press - July 7th, 2021
- Caribou eyes $100M IPO as it aims off-the-shelf CAR-Ts at the clinic - FierceBiotech - July 7th, 2021
- Genexine, Toolgen to co-develop CAR-NK cell gene therapy - Korea Biomedical Review - July 7th, 2021
- Reversal of biological age detected in mouse and human embryos - BioNews - July 7th, 2021
- Century Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase - GlobeNewswire - June 25th, 2021
- Univ. of Washington and Sana researchers use gene editing to prep stem cells for heart repair - GeekWire - June 25th, 2021
- Ubiquitination is essential for recovery of cellular activities after heat shock - Science Magazine - June 25th, 2021
- The CCL2-CCR2 astrocyte-cancer cell axis in tumor extravasation at the brain - Science Advances - June 25th, 2021
- Pharmacogenomic approach to cure the pain of the 'burning man' - Lab + Life Scientist - June 25th, 2021
- The Stem Cell Assay Market To Grow Through Mergers Amongst Market Participants The Courier - The Courier - June 25th, 2021
- Accelerated Biosciences' Immune-Privileged Human Trophoblast Stem Cells (hTSCs) Offer Breakthrough Opportunities in Cancer-Targeting Therapeutics and... - May 15th, 2021
- Study Models the Effect of Herpes Infection on Fetal Brain Development - Pharmacy Times - May 15th, 2021
- Induced Pluripotent Stem Cells Market is set for Lucrative Growth | Top Companies Thermo Fisher Scientific Inc., FUJIFILM Corporation, KSU | The... - May 15th, 2021
- Stem Cell Therapy Market by Type, Therapeutic Application and Cell Source - Global Forecasts to 2026 - ResearchAndMarkets.com - Business Wire - May 15th, 2021
- Global Induced Pluripotent Market Showing Impressive Growth by 2027||Thermo Fisher Scientific; Cell Applications, Inc.; Axol Bioscience Ltd.;... - May 15th, 2021
- Global Induced Pluripotent Stem Cells Market 2020 Top Manufactures, Growth Opportunities and Investment Feasibility 2025 The Courier - The Courier - May 3rd, 2021
- Stem Cell Therapy Market worth $401 million by 2026 - Exclusive Report by MarketsandMarkets - PRNewswire - May 3rd, 2021
- Fate Therapeutics Announces Four Presentations at the 2021 ASGCT Annual Meeting - GlobeNewswire - May 3rd, 2021
- Induced Pluripotent Stem Cells (iPSCs) Market 2021 Is Booming Across the Globe by Share, Size, Growth, Segments and Forecast to 2027 | Top Players... - May 3rd, 2021
- Induced Pluripotent Stem Cells (iPSCs) Market 2021 Industry Size, Share, Growth and Top Companies Analysis- Fujifilm Holding Corporation (CDI),... - May 3rd, 2021
- A New CRISPR Tool Flips Genes On and Off Like a Light Switch - Singularity Hub - May 3rd, 2021
- Stem Cell Characterization Kits Market Report 2021 by Global Key Players, Types, Applications, Countries, Size, Forecast to 2027 Good News Gum - Good... - May 3rd, 2021
- Induced Pluripotent Stem Cells Market Growth Opportunities, Analysis and Forecasts Report 2020-2026 with key players position (Fujifilm Holding... - February 17th, 2021
- Cytovia Therapeutics and Cellectis Partner to Develop TALEN Gene-Edited iPSC-Derived Natural Killer Cells - BioSpace - February 17th, 2021
- Can we freeze them? Yes we can, says Nkarta - Vantage - February 17th, 2021
- Global Induced Pluripotent Market Positive Outlook, Revenue Generation & Leading Manufacturers, Forecast 2026||CELGENE CORPORATION; Astellas... - February 17th, 2021
- Induced Pluripotent Stem Cells Market Growth, Competitive Landscape, Research Methodology, Business Opportunities, Statistics and Industry Analysis... - February 17th, 2021
- Evotec and Medical Center Hamburg-Eppendorf Enter Partnership to Develop iPSC-Based Tissue Therapy f - PharmiWeb.com - February 4th, 2021
- Breakthrough stem cell therapy may reverse life-threatening conditions in dogs - Study Finds - February 4th, 2021
- SLAS Technology Special Collection on Artificial Intelligence in Process Automation Available Now - Newswise - February 4th, 2021
- Exacis Biotherapeutics Announces Key Addition To Its Executive Leadership Team With Dirk Huebner MD Joining As Chief Medical Officer - PRNewswire - February 4th, 2021
- Induced Pluripotent Stem Cells Market 2020 Global Share, Growth, Size, Opportunities, Trends, Regional Overview, Leading Company Analysis And Forecast... - February 4th, 2021
- Money on the Move: January 27 February 2 - BioSpace - February 4th, 2021
- Poultry Healthcare Products Market Share, Growth, Statistics, by Application, Production, Revenue & Forecast to 2025 - AlgosOnline - January 27th, 2021
- Impact Of Covid 19 On Stem Cells Industry 2020 Market Challenges, Business Overview And Forecast Research Study 2026 Murphy's Hockey Law - Murphy's... - January 27th, 2021
- SREBP1 suppresses the differentiation and epithelial function of hiPSC-derived endothelial cells by inhibiting the microRNA199b-5p pathway - DocWire... - January 25th, 2021
- Induced Pluripotent Stem Cells Market Segmentation and Analysis by Latest Trends, Development and Growth by Trending Regions 2020 with key players... - January 25th, 2021
- Induced Pluripotent Stem Cells (iPSCs) Market to Witness Massive Growth During 2021-2027 | Fujifilm Holding Corporation (CDI), Ncardia, Sumitomo... - January 25th, 2021
- Hands across the water as bio bonds stand test of time | Business Weekly - Business Weekly - January 25th, 2021
- Exercise mimetics and JAK inhibition attenuate IFN-induced wasting in engineered human skeletal muscle - Science Advances - January 25th, 2021
- Can Science Save the Northern White Rhino? - Freethink - January 25th, 2021
- Induced Pluripotent Stem Cells Market to Grow with an Impressive CAGR - Farming Sector - January 9th, 2021
- Accelerating cell-based therapies by providing safe therapeutic MSC products - BioSpace - January 9th, 2021
- Exacis Biotherapeutics Announces Its Launch and mRNA Technology In-Licensing For Targeted CAR-NK And CAR-T Cell Cancer Therapies | DNA RNA and Cells |... - January 9th, 2021
- Environmental Factor - January 2021: Intramural Papers of the Month - Environmental Factor Newsletter - January 9th, 2021
- Global Induced Pluripotent Stem Cells Market To Witness Huge Gains Over 2020-2026 - Factory Gate - December 28th, 2020
- Exosomes act as messengers and decoys to save healthy cells from viral infection - Massive Science - December 28th, 2020
- Scientists have restored youth to aging eyes in mice - Massive Science - December 21st, 2020
- Top Technical Advances of 2020 - The Scientist - December 21st, 2020
- A new psychedelic drug gives psychiatric benefits without causing hallucinations - Massive Science - December 21st, 2020
- I Peace, Inc. and Avery Therapeutics announce collaboration to bring iPSC derived cell therapy for heart failure to the clinic - PRNewswire - December 17th, 2020
- Network of Genes Involved in Congenital Heart Disease Identified - Technology Networks - December 17th, 2020
- Global Induced Pluripotent Market 2020-26 Steering Forces Heading Towards Impressive CAGR With CELGENE CORPORATION; Astellas Pharma Inc.; Thermo... - December 17th, 2020
- Global Induced Pluripotent Stem Cells (iPSCs) Market Expectable to Exceed Global Market Revenue, Size, Segments and Market Competition Trend to... - December 14th, 2020
- Evotec and Sartorius Partner with Start-Up Curexsys on IPSC-Based Therapeutic Exosome Approach - BioSpace - December 9th, 2020
- Multiple gene edits and computer simulations could help treat rare genetic diseases - University of Wisconsin-Madison - December 9th, 2020
- Cytovia Therapeutics announces plans to initiate in 2021 Clinical Development of Universal iPSC NK Cell Therapy for Hematological and Solid Tumors -... - December 9th, 2020
- Fate Therapeutics Reports Positive Interim Data from its Phase 1 Study of FT516 in Combination with Rituximab for B-cell Lymphoma - GlobeNewswire - December 9th, 2020
- Constantly Growing Applications and Innovations to Push Sales of Amniotic Membrane Market Up To ~US$2.4 Bn by 2027, Observes TMR - PRNewswire - December 9th, 2020
- Tulane researcher shows enhanced therapeutic stem cell migration improves neurodegenerative disease - News from Tulane - December 8th, 2020
- Researchers restore lost sight in mice, offering clues to reversing aging - Science Magazine - December 8th, 2020
- Fate Therapeutics Reports Positive Interim Data from its Phase 1 Study of FT516 in Combination with Rituximab for B-cell Lymphoma | DNA RNA and Cells... - December 8th, 2020
- Bayer and Atara Biotherapeutics in CAR T-cell therapy deal - BioPharma-Reporter.com - December 8th, 2020
- Repairing the Brain With Stem Cells? A Conversation With Prof. Jack Price - Being Patient - December 3rd, 2020
- Global Induced Pluripotent Stem Cells Market Size, Comprehensive Analysis, Development Strategy, Future Plans and Industry Growth with High CAGR by... - December 3rd, 2020
- Industry Verticals: Induced Pluripotent Stem Cells (iPSC) Market Latest and updated Scope and Application 2020-2027 - The Blend - December 3rd, 2020
- Bayer Launches Cell and Gene Therapy Platform to Maximize Recent Acquisitions - PharmaLive - December 3rd, 2020
- Stem Cells Market Size on Target to Reach US$ 17.79 Billion 2027 - Cheshire Media - December 3rd, 2020
- Bayer establishes Cell and Gene Therapy Platform to accelerate pharmaceutical innovation | More News | News Channels - PipelineReview.com - December 3rd, 2020
- Growing Value of Stem Cells in Medicine to Create a US$2,4 Billion Opportunity for Induced Pluripotent Stem Cell ((iPSC) - GlobeNewswire - November 27th, 2020
- Induced Pluripotent Stem Cells (iPSCs) Market Applications, Types and Future Ou - News by aeresearch - November 27th, 2020
- Research Paper Showing ProtoKinetix AAGP Enhanced Stem Cell Derived Retina Precursor Cells Restoration of Vision - Business Wire - November 27th, 2020
- Induced Pluripotent Stem Cells Market 2020: Enhanced Growth, Recent Trends and Major Companies are Fujifilm Holding Corporation, Astellas Pharma, Fate... - November 27th, 2020